| Filed On | Filing |
|---|---|
| 02 Oct 2026 |
Form 4: Fung Peter K, Director
Granted 3,286 Stock Options (Right to Buy) ($6.24K) |
| 02 Oct 2026 |
Form 4: Betts Wendy J, Director
Granted 3,286 Stock Options (Right to Buy) ($6.24K) |
| 02 Oct 2026 |
Form 4: Burton Paul Frederick, Director
Granted 3,286 Stock Options (Right to Buy) ($6.24K) |
| 02 Oct 2026 |
Form 4: Intrater James, Director
Granted 3,286 Stock Options (Right to Buy) ($6.24K) |
| 18 Sep 2026 |
8-K: Submission of Matters to a Vote of Security Holders
On September 18, 2026, Cardio Diagnostics Holdings, Inc., a Delaware corporation (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). Of the Company’s 2,959,469 shares of common stock issued and outstanding and... |
| 08 Sep 2026 | DEFINITIVE 14A ADDITIONAL MATERIALS |
| 20 Aug 2026 | 8-K: Regulation FD Disclosure |
| 07 Aug 2026 | DEFINITIVE 14A ADDITIONAL MATERIALS |
| 07 Aug 2026 | QUARTERLY REPORT |
| 05 Aug 2026 | Proxy statement: annual meeting on September 18, 2026 |
| 23 Jul 2026 | ANNUAL REPORT TO SECURITY HOLDERS |
| 13 Jul 2026 | PRELIMINARY 14A |
| 02 Jul 2026 |
Form 4: Fung Peter K, Director
Granted 2,854 Stock Options (Right to Buy) ($6.25K) |
| 02 Jul 2026 |
Form 4: Betts Wendy J, Director
Granted 2,854 Stock Options (Right to Buy) ($6.25K) |
| 02 Jul 2026 |
Form 4: Intrater James, Director
Granted 2,854 Stock Options (Right to Buy) ($6.25K) |
| 02 Jul 2026 |
Form 4: Burton Paul Frederick, Director
Granted 2,854 Stock Options (Right to Buy) ($6.25K) |
| 15 May 2026 | QUARTERLY REPORT |
| 02 Apr 2026 |
Form 4: Fung Peter K, Director
Granted 3,205 Stock Options (Right to Buy) ($6.25K) |
| 02 Apr 2026 |
Form 4: Betts Wendy J, Director
Granted 3,205 Stock Options (Right to Buy) ($6.25K) |
| 02 Apr 2026 |
Form 4: Intrater James, Director
Granted 3,205 Stock Options (Right to Buy) ($6.25K) |
Loading...
